Tech Company Financing Transactions

IgGenix Funding Round

On 8/5/2020, IgGenix secured $10 million in Series A funding from Khosla Ventures and Parker Price Venture Capital.

Transaction Overview

Company Name
Announced On
8/5/2020
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Proceeds Purpose
The financing will be used to advance the company's novel antibody therapeutics platform for the treatment of food and non-food allergies and other severe allergic conditions.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
329 Oyster Point Blvd. 3rd Floor
San Francisco, CA 94080
USA
Email Address
Overview
IgGenix is a privately-held biotechnology company taking a revolutionary approach to directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade.
Profile
IgGenix LinkedIn Company Profile
Social Media
IgGenix Company Twitter Account
Company News
IgGenix News
Facebook
IgGenix on Facebook
YouTube
IgGenix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jessica Grossman
  Jessica Grossman LinkedIn Profile  Jessica Grossman Twitter Account  Jessica Grossman News  Jessica Grossman on Facebook
Chief Scientific Officer
Richard Boismenu
  Richard Boismenu LinkedIn Profile  Richard Boismenu Twitter Account  Richard Boismenu News  Richard Boismenu on Facebook
Chief Technical Officer
Derek Croote
  Derek Croote LinkedIn Profile  Derek Croote Twitter Account  Derek Croote News  Derek Croote on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/5/2020: Indigo Ag venture capital transaction
Next: 8/5/2020: Rippling venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary